Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
The Pediatric Easy Dosing System aims to eliminate medication administration errors in pediatric care
The medics were wearing seatbelts; no one was seriously injured
The 10-year paramedic told police he stole two vials of Dilaudid with the intention of killing himself
Sen. Claire McCaskill said Missouri needs more tools to fight opiate abuse, including a prescription drug monitoring program and better research about average drug use
The $3.7 million package includes funding for 10 additional agents for the Maine Drug Enforcement Agency
A new study found that the higher a cardiac arrest patient lives, the lower the chances of survival
The woman died in her home hours after returning from the ER with a prescription for opioid painkillers
The bill would limit initial opiate painkiller prescriptions to a seven-day supply and set an evaluation requirement for overdose victims seeking help at hospital ERs
If the act is not passed, EMS providers could be prevented from accessing controlled substances to treat pain and seizures
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.